Fabrication and in vitro–in vivo evaluation of ligand appended isoniazid loaded nanoparticulate systems for the treatment of tuberculosis

References

• Global Tuberculosis. Programme. https://www.who.int/teams/global-tuberculosis-programme/tb-reports. (accessed Oct 18, 2023).
   Google Scholar
• Sosnik, A.; Carcaboso, Á. M.; Glisoni, R. J.; Moretton, M. A.; Chiappetta, D. A. New Old Challenges in Tuberculosis: Potentially Effective Nanotechnologies in Drug Delivery. Adv. Drug Deliv. Rev. 2010, 62, 547–559. DOI: 10.1016/j.addr.2009.11.023.
   PubMed Web of Science ®Google Scholar
• Squibb, B.; Index, M. Isoniazid. Tuberculosis. 2008, 88, 112–116. DOI: 10.1016/S1472-9792(08)70011-8.
   PubMedGoogle Scholar
• The Merck Index Online. Chemicals, Drugs and Biologicals. https://merckindex.rsc.org/. (accessed Oct 18, 2023).
   Google Scholar
• Rohit, B.; Pal, K. I. A Method to Prepare Solid Lipid Nanoparticles with Improved Entrapment Efficiency of Hydrophilic Drugs. CNANO. 2013, 9, 211–220. DOI: 10.2174/1573413711309020008.
   Google Scholar
• Metushi, I. G.; Cai, P.; Zhu, X.; Nakagawa, T.; Uetrecht, J. P. A Fresh Look at the Mechanism of Isoniazid-Induced Hepatotoxicity. Clin. Pharmacol. Ther. 2011, 89, 911–914. DOI: 10.1038/clpt.2010.355.
   PubMed Web of Science ®Google Scholar
• Maryam, S.; Bhatti, A. S. A.; Shahzad, A. W. Protective Effects of Silymarin in Isoniazid Induced Hepatotoxicity in Rabbits. Ann. King Edward Med. Univ. 1970, 16, 43.
   Google Scholar
• Chaudhary, S.; Garg, T.; Murthy, R. S. R.; Rath, G.; Goyal, A. K. Recent Approaches of Lipid-Based Delivery System for Lymphatic Targeting via Oral Route. J. Drug Target. 2014, 22, 871–882. DOI: 10.3109/1061186X.2014.950664.
   PubMed Web of Science ®Google Scholar
• Trevaskis, N. L.; Charman, W. N.; Porter, C. J. H. Lipid-Based Delivery Systems and Intestinal Lymphatic Drug Transport: A Mechanistic Update. Adv. Drug Deliv. Rev. 2008, 60, 702–716. DOI: 10.1016/j.addr.2007.09.007.
   PubMed Web of Science ®Google Scholar
• Porter, C. J. H.; Trevaskis, N. L.; Charman, W. N. Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs. Nat. Rev. Drug Discov. 2007, 6, 231–248. DOI: 10.1038/nrd2197.
   PubMed Web of Science ®Google Scholar
• Varshosaz, J.; Minayian, M.; Moazen, E. Enhancement of Oral Bioavailability of Pentoxifylline by Solid Lipid Nanoparticles. J. Liposome Res. 2010, 20, 115–123. DOI: 10.3109/08982100903161456.
   PubMed Web of Science ®Google Scholar
• Shete, H.; Patravale, V. Long Chain Lipid Based Tamoxifen NLC. Part I: Preformulation Studies, Formulation Development and Physicochemical Characterization. Int. J. Pharm. 2013, 454, 573–583. DOI: 10.1016/j.ijpharm.2013.03.034.
   PubMed Web of Science ®Google Scholar
• Chokshi, N. V.; Khatri, H. N.; Patel, M. M. Formulation, Optimization, and Characterization of Rifampicin-Loaded Solid Lipid Nanoparticles for the Treatment of Tuberculosis. Drug Dev. Ind. Pharm. 2018, 44, 1975–1989. DOI: 10.1080/03639045.2018.1506472.
   PubMed Web of Science ®Google Scholar
• Chokshi, N. V.; Rawal, S.; Solanki, D.; Gajjar, S.; Bora, V.; Patel, B. M.; Patel, M. M. Fabrication and Characterization of Surface Engineered Rifampicin Loaded Lipid Nanoparticulate Systems for the Potential Treatment of Tuberculosis: An in Vitro and in Vivo Evaluation. J. Pharm. Sci. 2021, 110, 2221–2232. DOI: 10.1016/j.xphs.2021.02.018.
   PubMed Web of Science ®Google Scholar
• Vinchhi, P.; Patel, M. M. Triumph against Cancer: Invading Colorectal Cancer with Nanotechnology. Expert Opin. Drug Deliv. 2021, 18, 1169–1192. DOI: 10.1080/17425247.2021.1889512.
   PubMed Web of Science ®Google Scholar
• Rawal, S. U.; Patel, M. M. Lipid Nanoparticulate Systems. In Lipid Nanocarriers for Drug Targeting; Elsevier: Oxford, United Kingdom, 2018; pp 49–138 DOI: 10.1016/B978-0-12-813687-4.00002-5.
   Google Scholar
• Shete, H.; Chatterjee, S.; De, A.; Patravale, V. Long Chain Lipid Based Tamoxifen NLC. Part II: Pharmacokinetic, Biodistribution and in Vitro Anticancer Efficacy Studies. Int. J. Pharm. 2013, 454, 584–592. DOI: 10.1016/j.ijpharm.2013.03.036.
   PubMed Web of Science ®Google Scholar
• Rawal, S. U.; Patel, B. M.; Patel, M. M. New Drug Delivery Systems Developed for Brain Targeting. Drugs. 2022, 82, 749–792. DOI: 10.1007/s40265-022-01717-z.
   PubMed Web of Science ®Google Scholar
• Rawal, S.; Patel, M. Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers. Nano-Micro Lett. 2021, 13, 142. DOI: 10.1007/s40820-021-00630-6.
   PubMed Web of Science ®Google Scholar
• Rostami, E.; Kashanian, S.; Azandaryani, A. H.; Faramarzi, H.; Dolatabadi, J. E. N.; Omidfar, K. Drug Targeting Using Solid Lipid Nanoparticles. Chem. Phys. Lipids. 2014, 181, 56–61. DOI: 10.1016/j.chemphyslip.2014.03.006.
   PubMed Web of Science ®Google Scholar
• Jain, N. K.; Mishra, V.; Mehra, N. K. Targeted Drug Delivery to Macrophages. Expert Opin. Drug Deliv. 2013, 10, 353–367. DOI: 10.1517/17425247.2013.751370.
   PubMed Web of Science ®Google Scholar
• Nimje, N.; Agarwal, A.; Saraogi, G. K.; Lariya, N.; Rai, G.; Agrawal, H.; Agrawal, G. P. Mannosylated Nanoparticulate Carriers of Rifabutin for Alveolar Targeting. J. Drug Target. 2009, 17, 777–787. DOI: 10.3109/10611860903115308.
   PubMed Web of Science ®Google Scholar
• Azarmi, S.; Roa, W. H.; Löbenberg, R. Targeted Delivery of Nanoparticles for the Treatment of Lung Diseases. Adv. Drug Deliv. Rev. 2008, 60, 863–875. DOI: 10.1016/j.addr.2007.11.006.
   PubMed Web of Science ®Google Scholar
• Saraogi, G. K.; Sharma, B.; Joshi, B.; Gupta, P.; Gupta, U. D.; Jain, N. K.; Agrawal, G. P. Mannosylated Gelatin Nanoparticles Bearing Isoniazid for Effective Management of Tuberculosis. J. Drug Target. 2011, 19, 219–227. DOI: 10.3109/1061186X.2010.492522.
   PubMed Web of Science ®Google Scholar
• Kaur, I. P.; Bhandari, R.; Bhandari, S.; Kakkar, V. Potential of Solid Lipid Nanoparticles in Brain Targeting. J. Control. Release. 2008, 127, 97–109. DOI: 10.1016/j.jconrel.2007.12.018.
   PubMed Web of Science ®Google Scholar
• Azad, A. K.; Rajaram, M. V. S.; Schlesinger, L. S. Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics. J. Cytol. Mol. Biol. 2014, 1, 2696–2700. DOI: 10.13188/2325-4653.1000003.
   Google Scholar
• Chokshi, N. V.; Khatri, H. N.; Patel, M. M. Fabrication and Optimization of Isoniazid Loaded Lipid Nanoparticulate Systems for the Treatment of Tuberculosis. Adv. Sci. Eng. Med. 2019, 11, 741–757. DOI: 10.1166/asem.2019.2418.
   Google Scholar
• Darwis, Y.; Ali Khan, A.; Mudassir, J.; Mohtar, N. Advanced Drug Delivery to the Lymphatic System: Lipid-Based Nanoformulations. Int. J. Nanomed. 2013, 8, 2733–2744. DOI: 10.2147/IJN.S41521.
   PubMed Web of Science ®Google Scholar
• Singh, I.; Swami, R.; Khan, W.; Sistla, R. Lymphatic System: A Prospective Area for Advanced Targeting of Particulate Drug Carriers. Expert Opin. Drug Deliv. 2014, 11, 211–229. DOI: 10.1517/17425247.2014.866088.
   PubMed Web of Science ®Google Scholar
• Yang, S.; Zhu, J.; Lu, Y.; Liang, B.; Yang, C. Body Distribution of Camptothecin Solid Lipid Nanoparticles after Oral Administration. Pharm. Res. 1999, 16, 751–757. DOI: 10.1023/a:1018888927852.
   PubMed Web of Science ®Google Scholar
• Tiwari, R.; Pathak, K. Nanostructured Lipid Carrier versus Solid Lipid Nanoparticles of Simvastatin: Comparative Analysis of Characteristics, Pharmacokinetics and Tissue Uptake. Int. J. Pharm. 2011, 415, 232–243. DOI: 10.1016/j.ijpharm.2011.05.044.
   PubMed Web of Science ®Google Scholar
• Singh, H.; Bhandari, R.; Kaur, I. P. Encapsulation of Rifampicin in a Solid Lipid Nanoparticulate System to Limit Its Degradation and Interaction with Isoniazid at Acidic PH. Int. J. Pharm. 2013, 446, 106–111. DOI: 10.1016/j.ijpharm.2013.02.012.
   PubMed Web of Science ®Google Scholar
• Dwivedi, P.; Khatik, R.; Khandelwal, K.; Taneja, I.; Raju, K. S. R.; Paliwal, S. K.; Dwivedi, A. K.; Mishra, P. R.; Wahajuddin. Pharmacokinetics Study of Arteether Loaded Solid Lipid Nanoparticles: An Improved Oral Bioavailability in Rats. Int. J. Pharm. 2014, 466 (1–2), 321–327. DOI: 10.1016/j.ijpharm.2014.03.036.
   PubMedGoogle Scholar
• Varshosaz, J.; Eskandari, S.; Tabbakhian, M. Freeze-Drying of Nanostructure Lipid Carriers by Different Carbohydrate Polymers Used as Cryoprotectants. Carbohydr. Polym. 2012, 88, 1157–1163. DOI: 10.1016/j.carbpol.2012.01.051.
   Web of Science ®Google Scholar
• Vinchhi, P.; Patel, J. K.; Patel, M. M. High-Pressure Homogenization Techniques for Nanoparticles. In Emerging Technologies for Nanoparticle Manufacturing; Springer International Publishing: Cham, 2021; pp 263–285 DOI: 10.1007/978-3-030-50703-9_11.
   Google Scholar
• Jain, A.; Agarwal, A.; Majumder, S.; Lariya, N.; Khaya, A.; Agrawal, H.; Majumdar, S.; Agrawal, G. P. Mannosylated Solid Lipid Nanoparticles as Vectors for Site-Specific Delivery of an anti-Cancer Drug. J. Control. Release. 2010, 148, 359–367. DOI: 10.1016/j.jconrel.2010.09.003.
   PubMed Web of Science ®Google Scholar
• Kumar, P. V.; Asthana, A.; Dutta, T.; Jain, N. K. Intracellular Macrophage Uptake of Rifampicin Loaded Mannosylated Dendrimers. J. Drug Target. 2006, 14, 546–556. DOI: 10.1080/10611860600825159.
   PubMed Web of Science ®Google Scholar
• Pinheiro, M.; Ribeiro, R.; Vieira, A.; Andrade, F.; Reis, S. Design of a Nanostructured Lipid Carrier Intended to Improve the Treatment of Tuberculosis. Drug Des. Devel. Ther. 2016, 10, 2467–2475. DOI: 10.2147/DDDT.S104395.
   PubMed Web of Science ®Google Scholar
• Gaspar, D. P.; Faria, V.; Gonçalves, L. M. D.; Taboada, P.; Remuñán-López, C.; Almeida, A. J. Rifabutin-Loaded Solid Lipid Nanoparticles for Inhaled Antitubercular Therapy: Physicochemical and in Vitro Studies. Int. J. Pharm. 2016, 497, 199–209. DOI: 10.1016/j.ijpharm.2015.11.050.
   PubMed Web of Science ®Google Scholar
• Sharma, G.; Chopra, K.; Puri, S.; Bishnoi, M.; Rishi, P.; Kaur, I. P. Topical Delivery of TRPsiRNA-Loaded Solid Lipid Nanoparticles Confer Reduced Pain Sensation via TRPV1 Silencing, in Rats. J. Drug Target. 2018, 26, 135–149. DOI: 10.1080/1061186X.2017.1350857.
   PubMed Web of Science ®Google Scholar
• Mathur, P.; Sharma, S.; Rawal, S.; Patel, B.; Patel, M. M. Fabrication, Optimization, and in Vitro Evaluation of Docetaxel-Loaded Nanostructured Lipid Carriers for Improved Anticancer Activity. J. Liposome Res. 2020, 30, 182–196. DOI: 10.1080/08982104.2019.1614055.
   PubMed Web of Science ®Google Scholar
• Rawal, S.; Bora, V.; Patel, B.; Patel, M. Surface-Engineered Nanostructured Lipid Carrier Systems for Synergistic Combination Oncotherapy of Non-Small Cell Lung Cancer. Drug Deliv. Transl. Res. 2021, 11, 2030–2051. DOI: 10.1007/s13346-020-00866-6.
   PubMed Web of Science ®Google Scholar
• Khatri, H.; Chokshi, N.; Rawal, S.; Patel, B. M.; Badanthadka, M.; Patel, M. M. Fabrication and in Vivo Evaluation of Ligand Appended Paclitaxel and Artemether Loaded Lipid Nanoparticulate Systems for the Treatment of NSCLC: A Nanoparticle Assisted Combination Oncotherapy. Int. J. Pharm. 2020, 583, 119386. DOI: 10.1016/j.ijpharm.2020.119386.
   PubMedGoogle Scholar
• Sinhmar, G. K.; Shah, N. N.; Rawal, S. U.; Chokshi, N. V.; Khatri, H. N.; Patel, B. M.; Patel, M. M. Surface Engineered Lipid Nanoparticle-Mediated Site-Specific Drug Delivery System for the Treatment of Inflammatory Bowel Disease. Artif. Cells. Nanomed. Biotechnol. 2018, 46, 565–578. DOI: 10.1080/21691401.2018.1463232.
   PubMed Web of Science ®Google Scholar
• Prabhakar, K.; Afzal, S. M.; Kumar, P. U.; Rajanna, A.; Kishan, V. Brain Delivery of Transferrin Coupled Indinavir Submicron Lipid Emulsions—Pharmacokinetics and Tissue Distribution. Colloids Surf. B Biointerf. 2011, 86, 305–313. DOI: 10.1016/j.colsurfb.2011.04.013.
   PubMed Web of Science ®Google Scholar
• Yang, L.; Geng, Y.; Li, H.; Zhang, Y.; You, J.; Chang, Y. Enhancement the Oral Bioavailability of Praziquantel by Incorporation into Solid Lipid Nanoparticles. Pharmazie. 2009, 64, 86–89. DOI: 10.1691/ph.2009.8140.
   PubMed Web of Science ®Google Scholar
• Li, S.; Ji, Z.; Zou, M.; Nie, X.; Shi, Y.; Cheng, G. Preparation, Characterization, Pharmacokinetics and Tissue Distribution of Solid Lipid Nanoparticles Loaded with Tetrandrine. AAPS Pharm. Sci. Tech. 2011, 12, 1011. DOI: 10.1208/s12249-011-9665-3.
   PubMed Web of Science ®Google Scholar
• Subedi, R. K.; Kang, K. W.; Choi, H.-K. Preparation and Characterization of Solid Lipid Nanoparticles Loaded with Doxorubicin. Eur. J. Pharm. Sci. 2009, 37, 508–513. DOI: 10.1016/j.ejps.2009.04.008.
   PubMed Web of Science ®Google Scholar
• Mathur, P.; Rawal, S.; Patel, B.; Patel, M. M. Oral Delivery of Anticancer Agents Using Nanoparticulate Drug Delivery System. Curr. Drug Metab. 2019, 20, 1132–1140. DOI: 10.2174/1389200220666191007154017.
   PubMed Web of Science ®Google Scholar
• Khatri, H.; Chokshi, N.; Rawal, S.; Patel, M. M. Fabrication, Characterization and Optimization of Artemether Loaded PEGylated Solid Lipid Nanoparticles for the Treatment of Lung Cancer. Mater. Res. Express. 2019, 6, 045014. DOI: 10.1088/2053-1591/aaf8a3.
   Web of Science ®Google Scholar
• Rawal, S.; Patel, B.; Patel, M. M. Fabrication, Optimisation and in Vitro Evaluation of Docetaxel and Curcumin Co-Loaded Nanostructured Lipid Carriers for Improved Antitumor Activity against Non-Small Cell Lung Carcinoma. J. Microencapsul. 2020, 37, 543–556. DOI: 10.1080/02652048.2020.1823498.
   PubMed Web of Science ®Google Scholar
• Luo, Y.; Chen, D.; Ren, L.; Zhao, X.; Qin, J. Solid Lipid Nanoparticles for Enhancing Vinpocetine’s Oral Bioavailability. J. Control. Release. 2006, 114, 53–59. DOI: 10.1016/j.jconrel.2006.05.010.
   PubMed Web of Science ®Google Scholar
• Sato, M. R.; Oshiro Junior, J. A.; Machado, R. T. A.; de Souza, P. C.; Campos, D. L.; Pavan, F.; da Silva, P. B.; Chorilli, M. Nanostructured Lipid Carriers for Incorporation of Copper(II) Complexes to be Used against Mycobacterium Tuberculosis. Drug Des. Devel. Ther. 2017, 11, 909–921. DOI: 10.2147/DDDT.S127048.
   PubMed Web of Science ®Google Scholar
• Vandal, O. H.; Nathan, C. F.; Ehrt, S. Acid Resistance in Mycobacterium Tuberculosis. J. Bacteriol. 2009, 191, 4714–4721. DOI: 10.1128/JB.00305-09.
   PubMed Web of Science ®Google Scholar
• Gao, Y.; Sarfraz, M. K.; Clas, S.-D.; Roa, W.; Löbenberg, R. Hyaluronic Acid-Tocopherol Succinate-Based Self-Assembling Micelles for Targeted Delivery of Rifampicin to Alveolar Macrophages. J. Biomed. Nanotechnol. 2015, 11, 1312–1329. DOI: 10.1166/jbn.2015.2091.
   PubMed Web of Science ®Google Scholar
• Benito-Gallo, P.; Franceschetto, A.; Wong, J. C. M.; Marlow, M.; Zann, V.; Scholes, P.; Gershkovich, P. Chain Length Affects Pancreatic Lipase Activity and the Extent and PH–Time Profile of Triglyceride Lipolysis. Eur. J. Pharm. Biopharm. 2015, 93, 353–362. DOI: 10.1016/j.ejpb.2015.04.027.
   PubMed Web of Science ®Google Scholar
• Kalaria, D. R.; Sharma, G.; Beniwal, V.; Ravi Kumar, M. N. V. Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In Vivo Pharmacokinetics and Toxicity Studies in Rats. Pharm. Res. 2009, 26, 492–501. DOI: 10.1007/s11095-008-9763-4.
   PubMed Web of Science ®Google Scholar
• Abdelwahed, W.; Degobert, G.; Fessi, H. Investigation of Nanocapsules Stabilization by Amorphous Excipients during Freeze-Drying and Storage. Eur. J. Pharm. Biopharm. 2006, 63, 87–94. DOI: 10.1016/j.ejpb.2006.01.015.
   PubMed Web of Science ®Google Scholar
• ICH. International Conference on Harmonization (ICH). Guidance for Industry: Q1A(R2) Stability Testing of New Drug Substances and Products. ICH Harmon. Tripart. Guidel., 2003, 4, 24.
   Google Scholar
• Chai, G.-H.; Xu, Y.; Chen, S.-Q.; Cheng, B.; Hu, F.-Q.; You, J.; Du, Y.-Z.; Yuan, H. Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and Their Related Cytotoxicology. ACS Appl. Mater. Interf. 2016, 8, 5929–5940. DOI: 10.1021/acsami.6b00821.
   PubMed Web of Science ®Google Scholar
• Saraogi, G. K.; Gupta, P.; Gupta, U. D.; Jain, N. K.; Agrawal, G. P. Gelatin Nanocarriers as Potential Vectors for Effective Management of Tuberculosis. Int. J. Pharm. 2010, 385, 143–149. DOI: 10.1016/j.ijpharm.2009.10.004.
   PubMed Web of Science ®Google Scholar
• Beloqui, A.; Coco, R.; Alhouayek, M.; Solinís, M. Á.; Rodríguez-Gascón, A.; Muccioli, G. G.; Préat, V. Budesonide-Loaded Nanostructured Lipid Carriers Reduce Inflammation in Murine DSS-Induced Colitis. Int. J. Pharm. 2013, 454, 775–783. DOI: 10.1016/j.ijpharm.2013.05.017.
   PubMed Web of Science ®Google Scholar
• Erokhina, M.; Rybalkina, E.; Barsegyan, G.; Onishchenko, G.; Lepekha, L. The Toxicity of Rifampicin Polylactic Acid Nanoparticles against Mycobacterium Bovis BCG and Human Macrophage THP-1 Cell Line. IOP Conf. Ser: Mater. Sci. Eng. 2015, 98, 012017. DOI: 10.1088/1757-899X/98/1/012017.
   Google Scholar
• Severino, P.; Andreani, T.; Jäger, A.; Chaud, M. V.; Santana, M. H. A.; Silva, A. M.; Souto, E. B. Solid Lipid Nanoparticles for Hydrophilic Biotech Drugs: Optimization and Cell Viability Studies (Caco-2 & HEPG-2 Cell Lines). Eur. J. Med. Chem. 2014, 81, 28–34. DOI: 10.1016/j.ejmech.2014.04.084.
   PubMed Web of Science ®Google Scholar
• Pizzol, C.; Filippin-Monteiro, F.; Restrepo, J.; Pittella, F.; Silva, A.; Alves de Souza, P.; Machado de Campos, A.; Creczynski-Pasa, T. Influence of Surfactant and Lipid Type on the Physicochemical Properties and Biocompatibility of Solid Lipid Nanoparticles. Int. J. Environ. Res. Public Health. 2014, 11, 8581–8596. DOI: 10.3390/ijerph110808581.
   PubMed Web of Science ®Google Scholar
• Song, X.; Lin, Q.; Guo, L.; Fu, Y.; Han, J.; Ke, H.; Sun, X.; Gong, T.; Zhang, Z. Rifampicin Loaded Mannosylated Cationic Nanostructured Lipid Carriers for Alveolar Macrophage-Specific Delivery. Pharm. Res. 2015, 32, 1741–1751. DOI: 10.1007/s11095-014-1572-3.
   PubMed Web of Science ®Google Scholar
• Chuan, J.; Li, Y.; Yang, L.; Sun, X.; Zhang, Q.; Gong, T.; Zhang, Z. Enhanced Rifampicin Delivery to Alveolar Macrophages by Solid Lipid Nanoparticles. J. Nanopart. Res. 2013, 15, 1634. DOI: 10.1007/s11051-013-1634-1.
   Web of Science ®Google Scholar
• Rivolta, I.; Panariti, A.; Lettiero, B.; Sesana, S.; Gasco, P.; Gasco, M. R.; Masserini, M.; Miserocchi, G. Cellular Uptake of Coumarin-6 as a Model Drug Loaded in Solid Lipid Nanoparticles. J. Physiol. Pharmacol. 2011, 62, 45–53.
   PubMed Web of Science ®Google Scholar
• Bhandari, R. A Sensitive HPLC Method for Determination of Isoniazid in Rat Plasma, Brain, Liver and Kidney. J. Chromatogr. Sep. Tech. 2012, 03, 1000128. DOI: 10.4172/2157-7064.1000128.
   Google Scholar
• European Medicines Agency ICH. Q2 (R1): Validation of Analytical Procedures: Text and Methodology. Int. Conf. Harmon. 2005, 2, 1–15.
   Google Scholar
• Pouplin, T.; Phuong, P. N.; Toi, P. V.; Nguyen Pouplin, J.; Farrar, J. Isoniazid, Pyrazinamide and Rifampicin Content Variation in Split Fixed-Dose Combination Tablets. PLoS One. 2014, 9, e102047. DOI: 10.1371/journal.pone.0102047.
   PubMed Web of Science ®Google Scholar
• Calleja, I.; Blanco-Príeto, M. J.; Ruz, N.; Renedo, M. J.; Dios-Viéitez, M. C. High-Performance Liquid–Chromatographic Determination of Rifampicin in Plasma and Tissues. J. Chromatogr. A 2004, 1031, 289–294. DOI: 10.1016/j.chroma.2003.12.041.
   PubMed Web of Science ®Google Scholar
• Patel, M. M.; Amin, A. F. Design and Optimization of Colon-Targeted System of Theophylline for Chronotherapy of Nocturnal Asthma. J. Pharm. Sci. 2011, 100, 1760–1772. DOI: 10.1002/jps.22406.
   PubMed Web of Science ®Google Scholar
• Patel, M. M.; Amin, A. F. Formulation and Development of Release Modulated Colon Targeted System of Meloxicam for Potential Application in the Prophylaxis of Colorectal Cancer. Drug Deliv. 2011, 18, 281–293. DOI: 10.3109/10717544.2010.538447.
   PubMed Web of Science ®Google Scholar
• Patel, M. M. Formulation and Development of Di-Dependent Microparticulate System for Colon-Specific Drug Delivery. Drug Deliv. Transl. Res. 2017, 7, 312–324. DOI: 10.1007/s13346-017-0358-7.
   PubMed Web of Science ®Google Scholar
• Patel, M. D.; Date, P. V.; Gaikwad, R. V.; Samad, A.; Malshe, V. C.; Devarajan, P. V. Comparative Evaluation of Polymeric Nanoparticles of Rifampicin Comprising Gantrez and Poly(Ethylene Sebacate) on Pharmacokinetics, Biodistribution and Lung Uptake following Oral Administration. J. Biomed. Nanotechnol. 2014, 10, 687–694. DOI: 10.1166/jbn.2014.1739.
   PubMed Web of Science ®Google Scholar
• Caliph, S. M.; Charman, W. N.; Porter, C. J. H. Effect of Short‐, Medium‐, and Long‐Chain Fatty Acid‐Based Vehicles on the Absolute Oral Bioavailability and Intestinal Lymphatic Transport of Halofantrine and Assessment of Mass Balance in Lymph‐Cannulated and Non‐Cannulated Rats. J. Pharm. Sci. 2000, 89, 1073–1084. DOI: 10.1002/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V.
   PubMed Web of Science ®Google Scholar
• Sinhmar, G. K.; Shah, N. N.; Chokshi, N. V.; Khatri, H. N.; Patel, M. M. Process, Optimization, and Characterization of Budesonide-Loaded Nanostructured Lipid Carriers for the Treatment of Inflammatory Bowel Disease. Drug Dev. Ind. Pharm. 2018, 44, 1078–1089. DOI: 10.1080/03639045.2018.1434194.
   PubMed Web of Science ®Google Scholar
• Aburahma, M. H.; Badr-Eldin, S. M. Compritol 888 ATO: A Multifunctional Lipid Excipient in Drug Delivery Systems and Nanopharmaceuticals. Expert Opin. Drug Deliv. 2014, 11, 1865–1883. DOI: 10.1517/17425247.2014.935335.
   PubMed Web of Science ®Google Scholar
• Shojai, F.; Pettersson, A. B.; Mäntylä, T.; Rosenholm, J. Electrostatic and Electrosteric Stabilization of Aqueous Slips of 3Y–ZrO2 Powder. J. Eur. Ceram. Soc. 2000, 20, 277–283. DOI: 10.1016/S0955-2219(99)00173-9.
   Web of Science ®Google Scholar
• Paliwal, R.; Rai, S.; Vaidya, B.; Khatri, K.; Goyal, A. K.; Mishra, N.; Mehta, A.; Vyas, S. P. Effect of Lipid Core Material on Characteristics of Solid Lipid Nanoparticles Designed for Oral Lymphatic Delivery. Nanomedicine. 2009, 5, 184–191. DOI: 10.1016/j.nano.2008.08.003.
   PubMed Web of Science ®Google Scholar
• Barzegar-Jalali, M.; Adibkia, K.; Valizadeh, H.; Shadbad, M. R. S.; Nokhodchi, A.; Omidi, Y.; Mohammadi, G.; Nezhadi, S. H.; Hasan, M. Kinetic Analysis of Drug Release from Nanoparticles. J. Pharm. Pharm. Sci. 2008, 11, 167–177. DOI: 10.18433/J3D59T.
   PubMed Web of Science ®Google Scholar
• Abd El-Tawab, A.; El-Hofy, F.; Nasr, E.; Sriranganathan, N.; Soliman, E. Screening the Activity of anti-Tuberculosis Drugs against M. Bovis BCG Connaught and M. Bovis BCG Pasteur Growing in J774A.1 Cell Line Macrophages. Benha Vet. Med. J. 2016, 31, 124–131. DOI: 10.21608/bvmj.2016.31237.
   Google Scholar
• Rojanarat, W.; Changsan, N.; Tawithong, E.; Pinsuwan, S.; Chan, H.-K.; Srichana, T. Isoniazid Proliposome Powders for Inhalation—Preparation, Characterization and Cell Culture Studies. Int. J. Mol. Sci. 2011, 12, 4414–4434. DOI: 10.3390/ijms12074414.
   PubMed Web of Science ®Google Scholar
• Garcia-Aguilar, T.; Espinosa-Cueto, P.; Magallanes-Puebla, A.; Mancilla, R. The Mannose Receptor is Involved in the Phagocytosis of Mycobacteria-Induced Apoptotic Cells. J. Immunol. Res. 2016, 2016, 3845247–3845214. DOI: 10.1155/2016/3845247.
   PubMed Web of Science ®Google Scholar
• D'Addio, S. M.; Baldassano, S.; Shi, L.; Cheung, L.; Adamson, D. H.; Bruzek, M.; Anthony, J. E.; Laskin, D. L.; Sinko, P. J.; Prud’homme, R. K. Optimization of Cell Receptor-Specific Targeting through Multivalent Surface Decoration of Polymeric Nanocarriers. J. Control. Release. 2013, 168, 41–49. DOI: 10.1016/j.jconrel.2013.02.004.
   PubMed Web of Science ®Google Scholar
• Jain, S. K.; Gupta, Y.; Jain, A.; Saxena, A. R.; Khare, P.; Jain, A. Mannosylated Gelatin Nanoparticles Bearing an anti-HIV Drug Didanosine for Site-Specific Delivery. Nanomedicine. 2008, 4, 41–48. DOI: 10.1016/j.nano.2007.11.004.
   PubMed Web of Science ®Google Scholar
• Loos, U.; Musch, E.; Jensen, J. C.; Mikus, G.; Schwabe, H. K.; Eichelbaum, M. Pharmacokinetics of Oral and Intravenous Rifampicin during Chronic Administration. Klin. Wochenschr. 1985, 63, 1205–1211. DOI: 10.1007/BF01733779.
   PubMedGoogle Scholar
• Hirota, K.; Hasegawa, T.; Nakajima, T.; Inagawa, H.; Kohchi, C.; Soma, G.-I.; Makino, K.; Terada, H. Delivery of Rifampicin–PLGA Microspheres into Alveolar Macrophages is Promising for Treatment of Tuberculosis. J. Control. Release. 2010, 142, 339–346. DOI: 10.1016/j.jconrel.2009.11.020.
   PubMed Web of Science ®Google Scholar
• Li, R.; Eun, J. S.; Lee, M.-K. Pharmacokinetics and Biodistribution of Paclitaxel Loaded in Pegylated Solid Lipid Nanoparticles after Intravenous Administration. Arch. Pharm. Res. 2011, 34, 331–337. DOI: 10.1007/s12272-011-0220-2.
   PubMed Web of Science ®Google Scholar
• Dodiya, S. S.; Chavhan, S. S.; Sawant, K. K.; Korde, A. G. Solid Lipid Nanoparticles and Nanosuspension Formulation of Saquinavir: Preparation, Characterization, Pharmacokinetics and Biodistribution Studies. J. Microencapsul. 2011, 28, 515–527. DOI: 10.3109/02652048.2011.590612.
   PubMed Web of Science ®Google Scholar
• Maincent, P.; Thouvenot, P.; Amicabile, C.; Hoffman, M.; Kreuter, J.; Couvreur, P.; Devissaguet, J. P. Lymphatic Targeting of Polymeric Nanoparticles after Intraperitoneal Administration in Rats. Pharm. Res. 1992, 9, 1534–1539. DOI: 10.1023/a:1015895804597.
   PubMed Web of Science ®Google Scholar
• Jani, P.; Halbert, G. W.; Langridge, J.; Florence, A. T. The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats. J. Pharm. Pharmacol. 2011, 41, 809–812. DOI: 10.1111/j.2042-7158.1989.tb06377.x.
   Google Scholar
• Hussell, T.; Bell, T. J. Alveolar Macrophages: Plasticity in a Tissue-Specific Context. Nat. Rev. Immunol. 2014, 14, 81–93. DOI: 10.1038/nri3600.
   PubMed Web of Science ®Google Scholar
• Largent, B. L.; Walton, K. M.; Hoppe, C. A.; Lee, Y. C.; Schnaar, R. L. Carbohydrate-Specific Adhesion of Alveolar Macrophages to Mannose-Derivatized Surfaces. J. Biol. Chem. 1984, 259, 1764–1769. DOI: 10.1016/S0021-9258(17)43473-9.
   PubMed Web of Science ®Google Scholar
• De Almeida, M. S.; Susnik, E.; Drasler, B.; Taladriz-Blanco, P.; Petri-Fink, A.; Rothen-Rutishauser, B. Understanding Nanoparticle Endocytosis to Improve Targeting Strategies in Nanomedicine. Chem. Soc. Rev. 2021, 50, 5397–5434. DOI: 10.1039/d0cs01127d.
   PubMed Web of Science ®Google Scholar
• McCright, J.; Naiknavare, R.; Yarmovsky, J.; Maisel, K. Targeting Lymphatics for Nanoparticle Drug Delivery. Front. Pharmacol. 2022, 13, 887402. DOI: 10.3389/fphar.2022.887402.
   PubMed Web of Science ®Google Scholar